This study demonstrates that both [18F]FB-Gol1and [18F]FB-GR20 radiopharmaceuticals bind to the rat 101.8 glioblastoma and may serve as promising candidates for the development of a diagnostic radiotracers for selective diagnosis of EGFR expression in glial tumors. The gene discussed is EGFR; the disease is glioblastoma.